Comparison between Kenrik Industries IPO and Speciality Medicines IPO.
Kenrik Industries IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Speciality Medicines IPO is a SME Bookbuilding proposed to list at BSE SME.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Turnaround Corporate Advisors Pvt.Ltd. | Ekadrisht Capital Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Mnm Stock Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Kenrik Industries IPO is up to ₹8.30 Cr whereas the issue size of the Speciality Medicines IPO is up to ₹0.00 Cr. The final issue price of Kenrik Industries IPO is ₹25.00 per share and of Speciality Medicines IPO is .
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹25.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | |
| Fresh Issue Size | 33,18,000 shares | 23,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.30 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 33,18,000 shares | 23,00,000 shares |
| Issue Size Total (Amount) | up to ₹8.30 Cr | up to ₹0.00 Cr |
Kenrik Industries IPO opens on Apr 29, 2025, while Speciality Medicines IPO opens on . The closing date of Kenrik Industries IPO and Speciality Medicines IPO is May 06, 2025, and , respectively.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 29, 2025 | |
| Issue Close | May 06, 2025 | |
| Basis Of Allotment (Tentative) | May 07, 2025 | |
| Initiation of Refunds (Tentative) | May 08, 2025 | |
| Credit of Share (Tentative) | May 08, 2025 | |
| Listing date (Tentative) | May 09, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Kenrik Industries IPO P/E ratio is 20.74, as compared to Speciality Medicines IPO P/E ratio of .
| Kenrik Industries IPO | Speciality Medicines IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Kenrik Industries Limited Financial Information (Restated)
| Speciality Medicines Limited Financial Information (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.996 | 62.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31.24 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 9.01% | 40.44% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.85% | 34.95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.06 | 0.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.21 | ₹7.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 8.62% | 27.36% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Kenrik Industries IPO Retail Individual Investors (RII) are offered 16,62,000 shares while in Speciality Medicines IPO retail investors are offered 16,62,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Kenrik Industries IPO and in Speciality Medicines IPO.
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,80,000 shares | |
| QIB | 0 shares | |
| NII | 16,56,000 shares | |
| RII | 16,62,000 shares | |
| Employee | ||
| Others | ||
| Total | 33,18,000 shares |
Kenrik Industries IPO subscribed 2.00x in total, whereas Speciality Medicines IPO subscribed .
| Kenrik Industries IPO | Speciality Medicines IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.20x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.79x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.00x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
